0001641172-25-021856.txt : 20250801 0001641172-25-021856.hdr.sgml : 20250801 20250801125423 ACCESSION NUMBER: 0001641172-25-021856 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Section 4(A)(5) exempts sales of securities to accredited investors when the total offering is less than $5,000,000 FILED AS OF DATE: 20250801 DATE AS OF CHANGE: 20250801 EFFECTIVENESS DATE: 20250801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scienture Holdings, Inc. CENTRAL INDEX KEY: 0001382574 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-553459 FILM NUMBER: 251175152 BUSINESS ADDRESS: STREET 1: 20 AUSTIN BLVD. CITY: COMMACK STATE: NY ZIP: 11725 BUSINESS PHONE: (800) 261 0281 MAIL ADDRESS: STREET 1: 20 AUSTIN BLVD. CITY: COMMACK STATE: NY ZIP: 11725 FORMER COMPANY: FORMER CONFORMED NAME: TRxADE HEALTH, INC DATE OF NAME CHANGE: 20210602 FORMER COMPANY: FORMER CONFORMED NAME: TRXADE GROUP, INC. DATE OF NAME CHANGE: 20140207 FORMER COMPANY: FORMER CONFORMED NAME: XCELLINK INTERNATIONAL INC. DATE OF NAME CHANGE: 20081230 D 1 primary_doc.xml X0708 D LIVE 0001382574 Scienture Holdings, Inc. 20 AUSTIN BLVD. COMMACK NY NEW YORK 11725 (866) 468-6535 DELAWARE None TRxADE HEALTH, INC TRXADE GROUP, INC. XCELLINK INTERNATIONAL INC. Corporation true Narasimhan Mani 20 Austin Blvd. Commack NY NEW YORK 11725 Executive Officer Director Shankar Hariharan 20 Austin Blvd. Commack NY NEW YORK 11725 Executive Officer Director Donald G. Fell 20 Austin Blvd. Commack NY NEW YORK 11725 Director Mayur Doshi 20 Austin Blvd. Commack NY NEW YORK 11725 Director Subbarao Jayanthi 20 Austin Blvd. Commack NY NEW YORK 11725 Director Pharmaceuticals Decline to Disclose 06b 4a5 false 2025-07-18 false true false 50000 3000000 1300000 1700000 false 4 0 0 0 Proceeds are to be used for general working capital purposes, which may include payment of ordinary course remuneration to officers. false Scienture Holdings, Inc. /s/ Narasimhan Mani Narasimhan Mani Co-CEO and President 2025-08-01